Abstract:
An optical device for projection display system comprising:
a LCD projector, a luminescent spot projector for forming a luminescent spot on a screen, a luminescent spot extracting means for extracting light from the luminescent spot out of a reflected light from the screen, a luminescent spot detecting means for detecting the reflected luminescent spot and a luminescent control means for controlling a display image forming operation of the LCD projector based on the detection signal wherein the luminescent spot extracting means is an holographic mirror optically processed at, at least one wavelength of the luminescent spot projector.
Abstract:
Disclosed are compounds, compositions, and methods useful for disrupting protein interactions in a histone deacetyl ase (HD AC) complex in a cell of subject or for treating a disease mediated by a histone deacetyl ase (HD AC) complex in a subject.
Abstract:
The invention relates to the field of biochemistry, molecular biology and microbiology. More specific the invention relates to methods and means for metabolic engineering and improved product formation by a filamentous micro-organism or a low G+C gram-positive bacterium. The invention discloses that DasR and DasR binding sites play an important and universal role in the control of gene expression in micro-organisms Based on this finding, the invention provides multiple useful applications, such as a method for regulating the expression of a gene of interest, a method for controlling metabolism, a method for decreasing undesired expression and many more. Moreover, the invention also provides means that can be used to establish said methods: for example a micro-organism in which the DasR binding site in operable linkage with a particular gene has been modified to obtain increased or decreased expression of a protein (being a desired or undesired protein) encoded by said gene.
Abstract:
This invention is related to a method for detecting toxic and non-toxic cyanobacteria. The method comprises that nucleic acid from a biological sample is brought into contact with an oligonucleotide designed to be specific for particular regions of the mcy E gene, the mcy E in combination with mcyD, and with an oligonucleotide designed to be specific for 16SrDNA, and the presence or absence of toxic cyanobacteria is detected by a suitable molecular biology method. The invention is related also to oligonucleotides used in the method.
Abstract:
A portable holographic marking unit (30) for providing holographic markings on a substrate (24) is described. The unit includes a handle (32) which forms an outer casing for the portable unit and inner casing to mount components of the unit. The components include an internally mounted light source (44) which is partially encapsulated by the inner casing and provides illumination for the unit on the substrate. Another component is a transparent quartz window which, with the inner casing, passes the illumination of the internally mounted light source to the substrate. Additionally, a reflector is positioned between the internally mounted light source and the inner casing to redirect the illumination from the light source through the window and onto the substrate.
Abstract:
A portable holographic marking unit for providing holographic markings on a substrate is described. The unit includes a handle which forms an outer casing for the portable unit and inner casing to mount components of the unit. The components include an internally mounted light source which is partially encapsulated by the inner casing and provides illumination for the unit on the substrate. Another component is a transparent quartz window which, with the inner casing, passes the illumination of the internally mounted light source to the substrate. Additionally, a reflector is positioned between the internally mounted light source and the inner casing to redirect the illumination from the light source through the window and onto the substrate.
Abstract:
A polymer blend obtainable by a process comprising the steps of intimate mixing a biocompatible polymer able to form nanoparticles and a biocompatible interacting agent for making the polymeric blend susceptible for a drug to be administered which interacting agent is able to preserve the activity of the drug to be administered and which interacting agent is able to control the release of the drug to be administered.